Lung Cancer Clinical Trials

Showing 461-480 of 2,032 trials

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

NCT07053215

This randomized controlled trial investigated the efficacy and safety of argon-helium cryoablation combined with PD-1 inhibitors compared to PD-1 inhibitors plus chemotherapy for treating non-small cell lung cancer (NSCLC). The study aimed to evaluate differences in survival, tumor response, immune function, and adverse events.

Non-small Cell Lung Cancer (NSCLC)

The First Hospital of Hebei Medical University60 participantsStarted Dec 2020

Shijiazhuang, Hebei, China

ACTIVE_NOT_RECRUITING

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

NCT02284308

There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the subgroup of fit patients from frail patients.

NSCLC

Maastricht Radiation Oncology180 participantsStarted Jul 2016

Almelo, Netherlands • Apeldoorn, Netherlands • Arnhem, Netherlands +19 more locations

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Related Searches

A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients

Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Effect of Bilateral vs. Unilateral Alveolar Recruitment on Gas Exchange in Lung Resection

Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer

Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer

A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping

A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy